Literature DB >> 19516040

Anti-interleukin-5 therapy and severe asthma.

Sotirios Zarogiannis, Konstantinos I Gourgoulianis, Konstantinos Kostikas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19516040     DOI： 10.1056/NEJMc090685

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Application of quantitative pharmacology in development of therapeutic monoclonal antibodies.

Authors:  Mohammad Tabrizi; Cherryl Funelas; Hamza Suria
Journal:  AAPS J       Date:  2010-07-24       Impact factor: 4.009

Review 2.  Update in asthma 2009.

Authors:  Wendy C Moore; Rodolfo M Pascual
Journal:  Am J Respir Crit Care Med       Date:  2010-06-01       Impact factor: 21.405

3.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

4.  [Pulmonary allergic reactions].

Authors:  A R Koczulla; B Beutel; T Greulich; A Jerrentrup; C Vogelmeier
Journal:  Internist (Berl)       Date:  2012-08       Impact factor: 0.743

5.  SPLUNC1 deficiency enhances airway eosinophilic inflammation in mice.

Authors:  Jyoti V Thaikoottathil; Richard J Martin; Peter Y Di; Maisha Minor; Stephanie Case; Bicheng Zhang; Gongyi Zhang; Hua Huang; Hong Wei Chu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-12       Impact factor: 6.914

6.  Carbonic anhydrase IV is expressed on IL-5-activated murine eosinophils.

Authors:  Ting Wen; Melissa K Mingler; Benjamin Wahl; M Eyad Khorki; Oliver Pabst; Nives Zimmermann; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.